Training Effects on Fuel Metabolism (TrainMeUpMN)

January 6, 2026 updated by: University of Minnesota

The investigators are interested in how skeletal muscle processes fat and how this may affect insulin resistance. This is an important question since insulin resistance predates and predicts type 2 diabetes. The investigators are especially interested in learning about the effects of weight and training on insulin resistance. The investigators will study people before and after supervised aerobic or yoga training to identify differences in resting fat and sugar metabolism which may lead to differences in insulin resistance. The investigators will test these differences using stable isotopes, and the use of these stable isotopes is experimental.

Overweight/Obese Group: Eight visits will be required at the University of Minnesota Clinical Research Unit. Four visits will be done before training (screen and 3 pre-training visits), 1 visit during the training, and 3 post-training visits will be done. In between, the training will take about 16 weeks and will be a supervised treadmill program.

Lean/Trained Group: Four visits will be required at the University of Minnesota Clinical Research Unit (screen and 3 study visits).

Study Overview

Detailed Description

Insulin resistance plays a critical role in the development of type 2 diabetes (T2DM), with skeletal muscle the largest site of insulin resistance in the human body. In sedentary humans, insulin resistance correlates with levels of intramyocellular lipid (IMCL) and lipid metabolites that adversely affect skeletal muscle glucose metabolism. However, even modest endurance training has been shown to reduce insulin resistance while increasing skeletal muscle IMCL. Moreover, lean endurance trained participants have IMCL levels comparable to those of patients with T2DM, yet have significantly lower insulin resistance. These findings suggest that the physiological changes caused by training protect against lipid induced insulin resistance and that this protection is present even at rest, however our preliminary data suggest that training facilitates utilization of readily available fuel, with lipid preferentially used over glucose when available. We will test the overarching hypothesis that training increases resting skeletal muscle lipid metabolism, as measured by markers of IMCL lipolysis, accumulation of fatty acid metabolites and mitochondrial utilization of fatty acids.

Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1-TR002494. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Study Type

Interventional

Enrollment (Actual)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Minneapolis, Minnesota, United States, 55455
        • University of Minnesota

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

All subjects

  1. Subjects 18 to 40 years of age.
  2. Subjects are capable of giving informed consent

Overweight or obese

  1. Insulin resistant based on screening oral glucose tolerance testing.
  2. BMI 25 to 40 kg/m2 inclusive
  3. Stable weight for at least 3 months (± 5 lbs.)
  4. Sedentary status (self-report < 30 minutes/week regular exercise).

Lean, physically active

  1. physically active subjects defined as 3-5 aerobic exercise sessions/week
  2. matched to age and gender
  3. generally healthy with normal fasting glucose levels (glucose ≤100 mg/dL).

Exclusion Criteria:

All subjects

  1. Subjects 18 to 40 years of age.
  2. Subjects are capable of giving informed consent

Overweight or obese

  1. Insulin resistant based on screening oral glucose tolerance testing.
  2. BMI 25 to 40 kg/m2 inclusive
  3. Stable weight for at least 3 months (± 5 lbs.)
  4. Sedentary status (self-report < 30 minutes/week regular exercise).

Lean, physically active

  1. physically active subjects defined as 3-5 aerobic exercise sessions/week
  2. matched to age and gender
  3. generally healthy with normal fasting glucose levels (glucose ≤100 mg/dL).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Lean Trained
Metabolic control
Experimental: Obese or Overweight
Running Program Yoga Program
16 week supervised running program
once weekly supervised yoga

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Differences in insulin sensitivity between groups
Time Frame: Before and after exercise program (exercise program will take 16 weeks, expected average for evaluation will be 20 weeks)
Will use HOMA-IR and hyperinsulinemia-euglycemic clamp
Before and after exercise program (exercise program will take 16 weeks, expected average for evaluation will be 20 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Differences in fitness level between groups
Time Frame: before and after exercise program (exercise program will take 16 weeks, expected average for evaluation will be 20 weeks)
we will measure fitness level by treadmill based VO2 max testing.
before and after exercise program (exercise program will take 16 weeks, expected average for evaluation will be 20 weeks)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Differences in body composition between groups
Time Frame: before and after exercise program ((exercise program will take 16 weeks, expected average for evaluation will be 20 weeks)
we will measure body composition by iDEXA to look at changes and total fat, visceral fat, and subcutaneously pre-and post exercise. This will be a noninvasive x-ray based measurement (x-ray exposure is extremely low and is equivalent to 1 day of natural radiation in Minnesota)
before and after exercise program ((exercise program will take 16 weeks, expected average for evaluation will be 20 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lisa S. Chow, MD, University of Minnesota

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2014

Primary Completion (Actual)

December 30, 2018

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

May 22, 2014

First Submitted That Met QC Criteria

May 27, 2014

First Posted (Estimated)

May 30, 2014

Study Record Updates

Last Update Posted (Estimated)

January 8, 2026

Last Update Submitted That Met QC Criteria

January 6, 2026

Last Verified

January 1, 2026

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Subjects

Clinical Trials on Running Program

Subscribe